AU573786B2 - 1-phenyl-1,3,5-triazine-2,4,6-trione derivatives - Google Patents

1-phenyl-1,3,5-triazine-2,4,6-trione derivatives

Info

Publication number
AU573786B2
AU573786B2 AU39480/85A AU3948085A AU573786B2 AU 573786 B2 AU573786 B2 AU 573786B2 AU 39480/85 A AU39480/85 A AU 39480/85A AU 3948085 A AU3948085 A AU 3948085A AU 573786 B2 AU573786 B2 AU 573786B2
Authority
AU
Australia
Prior art keywords
triazine
phenyl
trione derivatives
trione
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU39480/85A
Other versions
AU3948085A (en
Inventor
Horst Boshagen
Helmut Brunner
Axel Haberkorn
Toyohiko Kume
Jurgen Stoltefuss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU3948085A publication Critical patent/AU3948085A/en
Application granted granted Critical
Publication of AU573786B2 publication Critical patent/AU573786B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/30—Only oxygen atoms
    • C07D251/34—Cyanuric or isocyanuric esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/38—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AU39480/85A 1984-03-09 1985-03-04 1-phenyl-1,3,5-triazine-2,4,6-trione derivatives Ceased AU573786B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843408768 DE3408768A1 (en) 1984-03-09 1984-03-09 IMMUNTIMULATING AGENTS
DE3408768 1984-03-09

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU18904/88A Division AU1890488A (en) 1984-03-09 1988-07-08 Cyanuric acid derivatives

Publications (2)

Publication Number Publication Date
AU3948085A AU3948085A (en) 1985-09-12
AU573786B2 true AU573786B2 (en) 1988-06-23

Family

ID=6230072

Family Applications (2)

Application Number Title Priority Date Filing Date
AU39480/85A Ceased AU573786B2 (en) 1984-03-09 1985-03-04 1-phenyl-1,3,5-triazine-2,4,6-trione derivatives
AU18904/88A Abandoned AU1890488A (en) 1984-03-09 1988-07-08 Cyanuric acid derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU18904/88A Abandoned AU1890488A (en) 1984-03-09 1988-07-08 Cyanuric acid derivatives

Country Status (8)

Country Link
EP (1) EP0158075A1 (en)
JP (1) JPS60208915A (en)
AU (2) AU573786B2 (en)
CA (1) CA1249516A (en)
DE (1) DE3408768A1 (en)
HU (1) HU201677B (en)
IL (1) IL74520A (en)
ZA (1) ZA851752B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703105A1 (en) * 1987-02-03 1988-08-11 Bayer Ag MEDICINE AGAINST PROTOCOES IN INSECTS
DE3703103A1 (en) * 1987-02-03 1988-08-11 Bayer Ag AGENT AGAINST FISH PARSITES
DE3805660A1 (en) * 1988-02-24 1989-09-07 Bayer Ag SUBSTITUTED 1,2,4-TRIAZINDIONES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE4228000A1 (en) * 1992-08-24 1994-03-03 Bayer Ag 3-aryl-triazine-2,4-diones
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
JP2001517223A (en) * 1997-04-02 2001-10-02 バイオニケ ライフ サイエンシーズ インコーポレイテッド Use of bacterial cell wall extracts for the prevention, treatment or elimination of protozoan or parasitic diseases
NZ520312A (en) 1999-12-28 2003-08-29 Bioniche Life Sciences Inc Hyaluronic acid in the treatment of cancer
DE10040110A1 (en) * 2000-08-17 2002-02-28 Bayer Ag Use of triazinetrione sulfoxides to combat coccidioses
CN103694185B (en) * 2013-12-18 2016-02-17 湖北龙翔药业有限公司 The preparation method of toltrazuril an alkali metal salt
MA52415A (en) 2018-02-26 2021-01-06 AlzeCure Pharma AB TRIAZINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH NEUROTROPHINS
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
GB201810669D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2710484A (en) * 1983-04-23 1984-10-25 Bayer Aktiengesellschaft 1-(4-(4-(fluoroalkyl-methyl-thio-,-sulphinyl-or-sulphonyl-) phenoxy)phenyl)-1,3,5-triazine triones
AU3872585A (en) * 1984-02-15 1985-08-22 Bayer Aktiengesellschaft 1-(4-(benzothia- or -oxazol-2-ylthio-or-2-yloxy) phenyl)-1, 3,5-triazine-2,4,6(1h 3h, 5h)-triones
AU561923B2 (en) * 1983-01-12 1987-05-21 Bayer Aktiengesellschaft Water miscible solution of 1-(3-methyl-4-(4:trifluors- methylthiophenoxy)phenyl)-3-methyl-1,3,5-triazin-2,4,6 (ih,3h,5h)-trione

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413722C3 (en) * 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen New 1- (4-phenoxyphenyl) -1,3,5-triazine derivatives, a process for their preparation and their use as pharmaceuticals
DE2650014A1 (en) * 1976-10-30 1978-05-03 Bayer Ag 1- (4-PHENOXY-PHENYL) -1,3,5-TRIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
DE2718799A1 (en) * 1977-04-27 1978-11-09 Bayer Ag 1- (4-PHENOXY-PHENYL) -1,3,5-TRIAZINE DERIVATIVES, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT AND GROWTH PROMOTER

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561923B2 (en) * 1983-01-12 1987-05-21 Bayer Aktiengesellschaft Water miscible solution of 1-(3-methyl-4-(4:trifluors- methylthiophenoxy)phenyl)-3-methyl-1,3,5-triazin-2,4,6 (ih,3h,5h)-trione
AU2710484A (en) * 1983-04-23 1984-10-25 Bayer Aktiengesellschaft 1-(4-(4-(fluoroalkyl-methyl-thio-,-sulphinyl-or-sulphonyl-) phenoxy)phenyl)-1,3,5-triazine triones
AU3872585A (en) * 1984-02-15 1985-08-22 Bayer Aktiengesellschaft 1-(4-(benzothia- or -oxazol-2-ylthio-or-2-yloxy) phenyl)-1, 3,5-triazine-2,4,6(1h 3h, 5h)-triones

Also Published As

Publication number Publication date
CA1249516A (en) 1989-01-31
JPS60208915A (en) 1985-10-21
IL74520A (en) 1988-06-30
DE3408768A1 (en) 1985-09-12
ZA851752B (en) 1985-11-27
AU3948085A (en) 1985-09-12
EP0158075A1 (en) 1985-10-16
HU201677B (en) 1990-12-28
IL74520A0 (en) 1985-06-30
HUT37605A (en) 1986-01-23
AU1890488A (en) 1988-11-03

Similar Documents

Publication Publication Date Title
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
AU565087B2 (en) 1,4-dihydro-4-oxonaphthyridine derivatives
AU550388B2 (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives
AU566416B2 (en) 1,8- - naphthyridine or hydroquineline derivatives
AU543928B2 (en) 4(311)-quinazolinone derivatives
AU570667B2 (en) 2-phenyl-3-oxo-3,4-dihydro-benzothiazine(1,4) derivatives
AU6675186A (en) Substituted 5,6-dialkoxyquinazoline derivatives
AU555036B2 (en) 1,4-dihydro-2,6-dimethyl-pyridine derivatives
AU573786B2 (en) 1-phenyl-1,3,5-triazine-2,4,6-trione derivatives
AU563950B2 (en) 2,2 -disubstituted-1,3-oxepine derivatives
AU2956484A (en) Benzoxadiazol-4-yl-1,4 dibyropyridine derivatives
AU1575383A (en) 1,4-dihyropyridine derivatives
AU577140B2 (en) 2,4-diamino-6-difluoromethylthio-1,3,5-triazine derivatives
AU569468B2 (en) 2,4 - diamino -s- (substituted) pyrimidines
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
AU547334B2 (en) 2,4-diaminopyrimidine derivatives
AU8413382A (en) 1,4-piperizine derivatives
AU4023085A (en) 1,2,4-triazacycloalkadiene derivatives
AU2469784A (en) 2,4(6)-diamino pyrimidines
AU568295B2 (en) 1,2,4-triazol-i-yl-propionitrile derivatives
AU8879882A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU572869B2 (en) 1,6-naphthyridin derivatives
AU3339584A (en) 1,2,4-triazolylmethyl - pyridyloxymethyl - carbinol derivatives
AU8879782A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
PT80882A (en) 4-substituted-1,2,4,6-thiatrizine derivatives